ELAVL4 and cancer: Four studies that included 3,613 patients (cancer patients/controls = 914/2,699) explored the diagnostic value of the panel of 7 TAAbs (p53, CAGE, NY-ESO-1, GBU4-5, SOX2, MAGE A4 and Hu-D).